Interestingly, similar to work in animal studies, treatment of patients with memory deficits (e.g., with schizophrenia) with exogenous neuropeptides such as arginine vasopressin has been shown to have potential therapeutic benefits for cognitive and memory functions [58]. Here, AVP is linked to schizophrenia.